ORBi: Archimbaud E. - Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia

Reference : Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16...


	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Hematology
	To cite this reference:	http://hdl.handle.net/2268/12372

Title :	Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia
Language :	English
Author, co-author :	Archimbaud, E. [ > > ]
	Jehn, U. [ > > ]
	Thomas, X. [ > > ]
	De Cataldo, F. [ > > ]
	Fillet, Georges [Université de Liège - ULg > Département des sciences cliniques > Hématologie - Oncologie médicale >]
	Belhabri, A. [ > > ]
	Peaud, P.-Y. [ > > ]
	Martin, C. [ > > ]
	Amadori, S. [ > > ]
	Willemze, R. [ > > ]
Publication date :	1999
Journal title :	Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K
Publisher :	Nature Publishing Group
Volume :	13
Pages :	843-849
ISSN :	0887-6924
e-ISSN :	1476-5551
City :	London
Country :	United Kingdom
Keywords :	[en] elderly AML ; treatment ; triple drug induction ; idarubicin vs mitoxantrone ; PBSC transplantation
Permalink :	http://hdl.handle.net/2268/12372

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Open access	143.pdf		Publisher postprint	102.72 kB	View/Open

All documents in ORBi are protected by a user license.